503. Minimally Effective Dose of Systemic AAV8-MTM1 Needed To Prolong Survival and Correct Severe Muscle Pathology in a Canine Model of X-Linked Myotubular Myopathy

David L. Mack, Martin K. Childers, Melissa Goddard et al.|Molecular Therapy|2015

Cited by 0